PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.
From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.
PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.
Only 25% of older populations have received a complete primary series of COVID-19 vaccines in lower income countries
The company has notified health authorities in markets where the drug is sold and has informed relevant healthcare professionals
How the responses to the COVID-19 pandemic have affected antibiotic-resistant bacteria
Between May and July 2022, over 170,500 people were referred for suspected lower gastro-intestinal cancers – up over 30,000 compared to the same period last year
Pharmaceutical Market Europe - July/ August 2022
A creative awakening – bringing innovation to patients; Parkinson’s disease and the microbiome; Rare diseases – changing the standard of care
Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app
Lucy Morgan is now managing director in the UK and Isabel Rojas is appointed head of planning in Europe
Why patient engagement is essential throughout the entire product life cycle
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...